A carregar...
Prophylactic vaccines are potent activators of monocyte-derived dendritic cells and drive effective anti-tumor responses in melanoma patients at the cost of toxicity
Dendritic cell (DC)-based immunotherapy is explored worldwide in cancer patients, predominantly with DC matured with pro-inflammatory cytokines and prostaglandin E(2). We studied the safety and efficacy of vaccination with monocyte-derived DC matured with a cocktail of prophylactic vaccines that con...
Na minha lista:
Publicado no: | Cancer Immunol Immunother |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Springer Berlin Heidelberg
2016
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4779136/ https://ncbi.nlm.nih.gov/pubmed/26861670 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00262-016-1796-7 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|